eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2020
vol. 6
 
Share:
Send email
Share:
abstract:
Original paper

Mac-2 binding protein in non-alcoholic fatty liver disease: Is it a reliable diagnostic biomarker? A pilot study

Rokaya Abd El-Aziz
1
,
Alshaimaa Rezk L R Alnaggar
1
,
Mona Ibrahim Mohamed Nabih
1
,
Shaimaa Mohammed Ali
1
,
Hany Khattab
2
,
Sahar Abd EL-Atty
3

  1. Internal Medicine Department, Kasr Alainy Hospital, Faculty of Medicine, Cairo University, Egypt
  2. Pathology Department, Kasr Alainy Hospital, Faculty of Medicine, Cairo University, Egypt
  3. Clinical and Chemical Pathology Department, Kasr Alainy Hospital, Faculty of Medicine, Cairo University, Egypt
Clin Exp HEPATOL 2020; 6, 1: 28–34
DOI: https://doi.org/10.5114/ceh.2020.93053
Online publish date: 2020/02/17
View full text Get citation
 
PlumX metrics:
Aim of the study
This study aimed to assess the level of serum Mac-2 binding protein (Mac-2BP) as a non-invasive biomarker for the diagnosis of non-alcoholic fatty liver disease (NAFLD).

Material and methods
Forty patients with NAFLD and 15 healthy sex- and age-matched subjects were included in this pilot study. Serum Mac-2BP level was measured using ELISA. Liver biopsy was taken from 20 patients.

Results
There was no statistically significant difference between patients and controls regarding the level of Mac-2BP (p = 0.209). Mac-2BP had a statistically significant correlation with the grade of lobular inflammation (r = 0.464, p = 0.039). The Mac-2BP cut-off value used for NASH prediction was 9.55 µg/ml, with sensitivity and specificity of 100% and 91.7%, respectively.

Conclusions
This study showed that Mac-2BP is not elevated in NAFLD patients compared to controls. It also demonstrated that the reliability of Mac-2BP as a biomarker for NAFLD diagnosis is still controversial and needs more investigation.

keywords:

Mac-2BP, biomarker, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.